Stocksigma LogoStocksigma Logo

Medicamen Organics Reports H1 FY27 Losses Amid Revenue Decline

Medicamen Organics reported a consolidated net loss of ₹414.78 Lakhs for the half-year ended 30th Sep'26, down from a net profit of ₹203.80 Lakhs in the

Medicamen Organics Reports H1 FY27 Losses Amid Revenue Decline

Medicamen Organics Ltd · Outcome · 15 Nov 2026, 3:49 am

Medicamen Organics Reports H1 FY27 Losses Amid Revenue Decline Medicamen Organics reported a consolidated net loss of ₹414.78 Lakhs for the half-year ended 30th Sep'26, down from a net profit of ₹203.80 Lakhs in the prior-year period, as consolidated revenue fell 60.85% YoY to ₹699.05 Lakhs. Standalone net loss stood at ₹405.46 Lakhs compared to a ₹193.82 Lakhs profit YoY. Statutory auditors highlighted non-provisions for pending litigations, unappealed GST demands of ₹138.28 Lakhs, and the exclusion of Rwandan subsidiary Depot Pharmacy Yego due to unavailable accounts amid East African geopolitical tensions.

Original exchange filing (PDF)

More announcements from Medicamen Organics Ltd

All Medicamen Organics Ltd announcements